C
As a medical device design group we often redesign existing products. Over time we have seen a great deal of difference in the level of compliance with design control requirements for products that have been approved and on the market in various countries (US, EU, Japan). I have been tasked with trying to understand why these differences exist and would very much appreciate any input. Thank you!